Skip to main content
Scott Friedman, MD, Gastroenterology, New York, NY

Scott L Friedman MD

Hepatology & Liver Transplantation


Professor, Medicine, Icahn School of Medicine

Join to View Full Profile
  • 1 Gustave L Levy PlNew York, NY 10029

  • Phone+1 212-241-7270

  • Fax+1 212-241-4465

Dr. Friedman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Gastroenterology, 1982 - 1985
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1980 - 1982
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1979

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1982 - Present
  • NY State Medical License
    NY State Medical License 1997 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Gastroenterology
    American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Fellow (AGAF) American Gastroenterological Association, 2007
  • Elected Member The American Society for Clinical Investigation, 1995
  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Journal Articles

  • Autophagy Is a Gatekeeper of Hepatic Differentiation and Carcinogenesis by Controlling the Degradation of Yap  
    Kirk N Campbell, Mark J Czaja, M Isabel Fiel, Kemal M Akat, Scott L Friedman, Nature
  • Mechanisms of NAFLD Development and Therapeutic Strategies  
    Arun J Sanyal, Mary Rinella, Scott L Friedman, Nature

Other

Press Mentions

  • A New Hub for Liver Research Tackles Its First Investigations
    A New Hub for Liver Research Tackles Its First InvestigationsOctober 7th, 2025
  • Mount Sinai Institute for Liver Research Established to Advance Understanding and Treatment of Liver Disease Amid Global Concerns
    Mount Sinai Institute for Liver Research Established to Advance Understanding and Treatment of Liver Disease Amid Global ConcernsMay 7th, 2025
  • Statins Appear to Guard Against Liver Disease Progression
    Statins Appear to Guard Against Liver Disease ProgressionMay 15th, 2023
  • Join now to see all

Grant Support

  • Training Program in Investigative Gastroenterology and HepatologyICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2023–2028
  • Hepatic stellate cells in NASH fibrosis and HCCICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2021–2025
  • Therapeutic antibodies for treating liver fibrosisABALONE BIO, INC.2020–2025
  • Role Of Stellate Cells In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases2011–2012
  • Autophagy During Hepatic Stellate Cell Activation In Alcoholic Liver InjuryNational Institute On Alcohol Abuse And Alcoholism2011
  • Project 2National Institute On Alcohol Abuse And Alcoholism2010–2011
  • Project 1National Institute On Alcohol Abuse And Alcoholism2010–2011
  • Pilot Feasibility Project #3National Institute On Alcohol Abuse And Alcoholism2010–2011
  • Pilot Feasibility Project #2National Institute On Alcohol Abuse And Alcoholism2010–2011
  • Pilot Feasibility Project #1National Institute On Alcohol Abuse And Alcoholism2010–2011
  • Oxidant Stress And Fibrosis In Alcoholic Liver InjuryNational Institute On Alcohol Abuse And Alcoholism2010–2011
  • Models CoreNational Institute On Alcohol Abuse And Alcoholism2010–2011
  • Mentoring Junior Faculty In Alcoholic Liver DiseaseNational Institute On Alcohol Abuse And Alcoholism2010–2011
  • Administrative CoreNational Institute On Alcohol Abuse And Alcoholism2010–2011
  • Training Program In Investigative GastroenterologyNational Institute Of Diabetes And Digestive And Kidney Diseases2010
  • The Role Of KLF6 Tumor Suppressor In Hepatocellular CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2010
  • Mentoring Junior Faculty In Alcoholic Liver DiseaseNational Institute On Alcohol Abuse And Alcoholism2009
  • International Symposium On Alcoholic Liver And Pancreatic Disease (ALPD)National Institute On Alcohol Abuse And Alcoholism2009
  • The Role Of KLF6 Tumor Suppressor In Hepatocellular CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2009
  • Project 2National Institute On Alcohol Abuse And Alcoholism2008–2009
  • Project 1National Institute On Alcohol Abuse And Alcoholism2008–2009
  • Pilot Feasibility Project #3National Institute On Alcohol Abuse And Alcoholism2008–2009
  • Pilot Feasibility Project #2National Institute On Alcohol Abuse And Alcoholism2008–2009
  • Pilot Feasibility Project #1National Institute On Alcohol Abuse And Alcoholism2008–2009
  • Oxidant Stress And Fibrosis In Alcoholic Liver InjuryNational Institute On Alcohol Abuse And Alcoholism2008–2009
  • Models CoreNational Institute On Alcohol Abuse And Alcoholism2008–2009
  • Administrative CoreNational Institute On Alcohol Abuse And Alcoholism2008–2009
  • The Role Of KLF6 In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
  • Training Program In Investigative GastroenterologyNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2009
  • Role Of KLF6 Tumor Suppressor In Hepatocellular CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2007
  • DDR2 Receptor Tyrosine Kinase In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
  • The Role Of Stellate Cells In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003
  • Lipocytes And Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1997–1998
  • Lipocytes And Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1997
  • The Role Of Lipocytes In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1993
  • R0le Of Lipocytes In Hepatic Fibrosis 0National Institute Of Diabetes And Digestive And Kidney Diseases1992
  • Role Of Lipocytes In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1989–1990
  • The Role Of Lipocytes In Hepatic Collagen MetabolismNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: